Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

HLA-DOA anticorps (N-Term)

Cet anticorps anti-HLA-DOA est un anticorps Lapin Polyclonal détectant HLA-DOA dans WB. Adapté pour Humain.
N° du produit ABIN1881420

Aperçu rapide pour HLA-DOA anticorps (N-Term) (ABIN1881420)

Antigène

Voir toutes HLA-DOA Anticorps
HLA-DOA (HLA Class II DO alpha (HLA-DOA))

Reactivité

  • 19
  • 2
  • 1
  • 1
  • 1
  • 1
Humain

Hôte

  • 19
  • 2
Lapin

Clonalité

  • 21
Polyclonal

Conjugué

  • 14
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp HLA-DOA est non-conjugé

Application

  • 13
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB)

Clone

RB42412
  • Épitope

    • 4
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 31-59, N-Term

    Purification

    This antibody is purified through a protein A column, followed by peptide affinity purification.

    Immunogène

    This HLA-DOA antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 31-59 amino acids from the N-terminal region of human HLA-DOA.

    Isotype

    Ig Fraction
  • Indications d'application

    WB: 1:1000

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C,-20 °C

    Date de péremption

    6 months
  • Antigène

    HLA-DOA (HLA Class II DO alpha (HLA-DOA))

    Autre désignation

    HLA-DOA

    Sujet

    Important modulator in the HLA class II restricted antigen presentation pathway by interaction with the HLA-DM molecule in B-cells. Modifies peptide exchange activity of HLA-DM.

    Poids moléculaire

    27599

    NCBI Accession

    NP_002110

    UniProt

    P06340

    Pathways

    Human Leukocyte Antigen (HLA) in Adaptive Immune Response
Vous êtes ici:
Chat with us!